Evidence map›Paper›PMID 19264358›Full record

ArticleLeukemia research2009

Estrogen treatment induces MLL aberrations in human lymphoblastoid cells.

Sabine Schnyder, Nga T Du, Hongan B Le, Sheetal Singh, Grace A Loredo, Andrew T Vaughan

Open access · greenAbstract read
In one paragraph

Article in Leukemia research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sabine SchnyderDepartment of Radiation Oncology, 4501 X Street, University of California Davis, Sacramento, CA 95817, USA.
Nga T Du
Hongan B Le
Sheetal Singh
Grace A Loredo
Andrew T Vaughan
University of California, Davis · US

Funding

RETROVIRUS PACKAGING, CONCENTRATING AND TITERINGP01CA105049 · NCI · LOYOLA UNIVERSITY CHICAGO · PI DIAZ, MANUEL ORESTES · 2005 to 2009
$6.5M
NCI NIH HHS P01 CA105049
6 · The paper itself

Abstract

Epidemiological data indicates increased risk of infant acute leukemia involving MLL gene aberrations with use of oral contraceptives. To determine whether estrogens might be implicated, we examined the effect of estradiol (E2) or 4-OH-E2 in an in vitro model of translocation susceptibility. Genomic DNA from the TK6 human lymphoblastoid cell line was screened by ligation mediated PCR and inverse PCR at a rearrangement hot spot within the MLL breakpoint cluster region to detect DNA aberrations. An increase in DNA double strand breaks was observed within this region after exposure to either E2 or 4-OH-E2. An increase in the frequency of MLL translocations was only found after exposure to E2. Induction of cleavage due to increased activation of apoptotic nucleases was excluded by pre-treatment with the pan-caspase inhibitor, zVAD.fmk. We conclude that concentrations of E2 and 4-OH-E2 that may occur during pregnancy, or during use of oral contraceptives, can cause aberrations of the MLL gene and could thus be a factor in the early events of leukemogenesis occurring in utero.

Indexed as

Annexin A5Antineoplastic AgentsApoptosisAryl Hydrocarbon HydroxylasesCell CycleCell Line, TumorChildChromosome AberrationsCloning, MolecularCytochrome P-450 CYP1B1DNA Topoisomerases, Type IEstradiolEstrogensEstrogens, CatecholFemaleFlow Cytometry4-hydroxyestradiolAnnexin A5Antineoplastic AgentsAryl Hydrocarbon HydroxylasesCYP1B1 protein, humanCytochrome P-450 CYP1B1DNA Topoisomerases, Type IEstradiolEstrogensEstrogens, CatecholHistone-Lysine N-MethyltransferaseKMT2A protein, humanMyeloid-Lymphoid Leukemia ProteinReceptors, Estrogen

Identifiers

PMID19264358
PMCPMC2758092
OpenAlexW1983896204

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.